News and Announcements
VeilMail CEO Interview
- Published June 11, 2015 2:48PM UTC
- Publisher Wholesale Investor
- Categories Executive Interviews
Security breaches and any related interruptions in the performance of services or applications, can result in direct financial losses, threaten organizations’ reputations, erode customer loyalties, attract negative press, and trigger significant fines and penalties. VeilMail addresses this by providing impenetrable data storage and guaranteed security in digital communications. Independent studies conducted penetration tests on VeilMail and confirmed it is the most secure messaging platform on the market today.
VeilMail software provides impenetrable data storage and guaranteed secure digital communications. According to a Cyber Research report in January 2015, VeilMail was found to be the most secure data storage platform available on the market today.
In 2014, USD67 billion was spent on the Cyber Security market, VeilMail targets the business to business sector of this market.
The sales have been budgeted to build up to $15m per annum over the next 36 months, and trials are under way in numerous countries.
To find out more about VeilMail, please listen to their CEO Mr Greg Roake.
Executive Interviews
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
